PTAB
IPR2018-01676
Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH
General
Filed
09/10/18
Institution04/02/19
FWD05/29/20
Close05/29/20
StatusFinal Written Decision
OutcomeUnpatentable
USPTOIPR2018-01676
Petitioner
Attorney
Name | Ratings |
---|---|
L5 A | |
L5 A | |
L5 A | |
L5 A |
No Attorneys
Respondent
Attorney
No Attorneys